HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells

European Journal of Immunology

Volumn 30, Issue 6, 2000, Pages 1623-1631

  King, Ashley ^a,b,c   Allan, David S J ^a,b,c   Bowen, Mark ^a,b,c   Powis, Simon J ^a,b,c   Joseph, Sarah ^a,b,c   Verma, Sanjay ^a,b,c   Hiby, Susan E ^a,b,c   McMichael, Andrew J ^a,b   Loke, Yung Wai ^a,b,c   Braud, Veronique M ^a,b,c  

^a Research Group in Human Reproductive Immunobiology   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

CD94; Decidua; HLA E; NK cell; Trophoblast

Indexed keywords

CD94 ANTIGEN; HLA E ANTIGEN; MONOCLONAL ANTIBODY;

ANTIGEN EXPRESSION; ARTICLE; CYTOTOXICITY; DECIDUA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; TROPHOBLAST;

ANTIGENS, CD; ANTIGENS, CD94; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; DECIDUA; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HLA-C ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LIGANDS; MEMBRANE GLYCOPROTEINS; PLACENTA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RECEPTORS, IMMUNOLOGIC; TRANSFECTION; TROPHOBLASTS;

EID: 0034075580     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200006)30:6<1623::AID-IMMU1623>3.0.CO;2-M     Document Type: Article

References (46)

1. Loke, Y. W. and King, A., Immunology of Human Implantation: Cell Biology and Immunology. Cambridge University Press, Cambridge 1995.
2. King, A. and Loke, Y. W., On the nature and function of human uterine granular lymphocytes. Immunol. Today 1991. 12: 432-435.
3. Verma, S., King, A. and Loke, Y. W., Expression of killer-cell inhibitory receptors (KIR) on human uterine NK cells, fur. J. Immunol. 1997. 27: 979-983.
4. Hiby, S. E., King, A., Sharkey, A. M. and Loke, Y. W., Human uterine NK cells have a similar repertoire of killer inhibitory and activatory receptors to those found in blood, as demonstrated by RT-PCR and sequencing. Mot. Immunol. 1997. 34: 419-430.
5. Miki, A., Ishikawa, Y., Yabe, T., Furukawa, H., Fujii, T., Tokunaga, K., Akaza, T., Tadokoro, K., Taketani, Y. and Juju, T., Human lymphocytes obtained from decidual tissue express killer activatory receptors as well as killer inhibitory receptors: analysis using a single strand conformation polymorphism method. Am. J. Reprod. Immunol. 1998. 39:271-278.
6. Braud, V. M., Allan, D. S. J., O'Callaghan, C. A., Soderstrom, K., D'Andréa, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., Lanier, L. L. and McMichael, A. J., HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998.391:795-799.
7. Borrego, F., Ulbrecht, M., Weiss, E. H., Coligan, J. E. and Brooks, A. G., Recognition of human histocompatibility leukocyte antigen (HLA-)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 1998. 187: 813-818.
8. Lee, N., Llano, M., Carreteros, M., Ishitani, A., Navarro, F., Löpez-Botet, M. and Geraghty, D. E., HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 1998. 95: 5199-5204.
9. Brooks, A. G., Borrego, F., Posen, P. E., Patamawenu, A., Scorzelli, C. J., Ulbrecht, M., Weiss, E. H. and Coligan, J. E., Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells. J. Immunol. 1999. 162:305-313.
10. Braud, V. M., Jones, E. Y. and McMichael A., The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur. J. Immunol. 1997. 27:1164-1169.
11. Braud, V. M., Allan, D. S. J., Wilson, D. and McMichael, A. J., TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr. Biol. 1997.8:1-10.
12. Lee, N., Goodie, D. R., Ishitani, A., Marquardt, H. and Geraghty, D. E., HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J. Immunol. 1998.160: 4951-4960.
13. King, A., Boocock, C., Sharkey, A., Gardner, L., Beretta, A., Siccardi, A. G. and Loke, Y. W., Evidence for the expression of HLA-C class I mRNA and protein by human first trimester trophoblast. J. Immunol. 1996.156: 2068-2076.
14. Loke, Y. W., King, A., Burrows, T. D., Gardner, L., Bowen, J. M., Hiby, S., Hewlett, S., Holmes, N. and Jacobs, D., Evaluation of trophoblast HLA-G antigen with a specific monoclonal antibody. Tissue Antigens 1997. 50: 135-146.
15. Hutter, H., Hammer, A., Blaschitz, A., Hartmann, M., Ebbesen, P., Dohr, G., Ziegler, A. and Uchanska-Ziegler, B., Expression of HLA class I molecules in human first trimester and term placenta trophoblast. Cell Tissue Res. 1996. 286:439-447.
16. McMaster, M. T. and Fisher, S. J., The fetal transplant: is HLA-G important? In Kempers, R. D., Haney, A. F. and Younger, J. B. (Eds.) Fertility and Reproductive Medicine, Elsevier 1998, p.661.
17. Sernee, M. F., Ploegh, H. L. and Schust, D. J., Why certain antibodies cross-react with HLA-A and HLA-G: epitope mapping of two common MHC class I reagents. Mol. Immunol. 1998. 35: 177-188.
18. King, A., Burrows, T. D., Hiby, S. E., Joseph, S., Verma, S., Lim, P. B., Gardner, L., Bowen, J. M., Ziegler, A., Uchanska Ziegler, B., Le Bouteiller, P. and Loke, Y. W., Surface expression of HLA-C antigen by human extravillous trophoblast. Placenta, in press.
19. Wei, X. and Orr, H. T., Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissue. Hum. Immunol. 1990.29: 131-142.
20. Ulbrecht, M., Honka, T., Person, S., Johnson, J. P. and Weiss, E. H., The HLA-E gene encodes two differentially regulated transcripts and a cell surface protein. J. Immunol. 1992. 149: 2945-2953.
21. Guillaudeux, T., Rodriguez, A.-M., Girr, M., Mallet, V., Ellis, S. A., Sargent, I. L., Fauchet, R., Alsat, E. and Le Bouteiller, P., Methylation status and transcriptional expression of the MHC class I loci in human trophoblast cells from term placenta. J. Immunol. 1995.154: 3283-3299.
22. King, A., Jokhi, P. P., Smith, S., Sharkey, A. and Loke, Y. W., Screening for cytokine mRNA expression in purified human villous and extravillous trophoblast populations using the reversetranscriptase polymerase chain reaction (RT-PCR). Cytokine 1995.7:364-371.
23. Rajagopalan, S. and Long, E. O., An HLA-G specific receptor expressed on all natural killer cells. J. Exp. Med. 1999. 187: 1093-1100.
24. Llano, M., Lee, N., Navarro, F., Garcia, P., Albar, J. P., Geragthy, D. E. and Löpez-Botet, M., HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur. J. Immunol. 1998. 28: 2854-2863.
25. Vales-Gomez, M., Reyburn, H. T., Erskine, R. A., Löpez-Botet, M. and Strominger, J. L., Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J. 1999.18: 4250-4260.
26. Navarro, F., Llano, M., Bellon, T., Colonna, M., Geraghty, D. E. and Lopez-Botet, M., The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur. J. Immunol. 1999.29:277-283.
27. Borges, L., Hsu, M.-L., Fanger, N., Kubin, M. and Cosman, D., A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J. Immunol. 1997.159: 5192-5196.
28. Colonna, M., Navarro, F., Bellen, T., Llano, M., Garcia, P., Samaridis, J., Angman, L., Cella, M. and López-Botet, M., A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 1997.186:1809-1818.
29. Fanger, N. A., Cosman, D., Peterson, L., Braddy, S. C., Maliszewski, C. R. and Borges, L., The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes. Eur. J. Immunol. 1998. 28: 3423-3434.
30. + NK cell clones. Int. Immunol. 1999.11:29-35.
31. Allan, D. S., Colonna, M., Lanier, L. L., Churakova, T. D., Abrams, J. S., Ellis, S. A., McMichael, A. J. and Braud, V. M., Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells. J. Exp. Med. 1999.189:1149-1156.
32. Ponte, M., Cantoni, C., Biassoni, R., Trdori-Cappai, A., Bentivoglio, G., Vitale, C., Bertone, S., Moretta, A., Moretta, L. and Mingari, M. C., Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells expres LIR-1 and CD94/NKG2A and acquire p49, and HLA-G1-specific receptor. Proc. Natl. Acad. Sci. USA 1999. 96: 5674-5679.
33. King, A., Birkby, C. and Loke, Y. W., Early human decidual cells exhibit NK activity against K562 cell line but not against first trimester trophoblast. Cell. Immunol. 1989.118:337-344.
34. King, A. and Loke, Y. W., Human trophoblast and JEG choriocarcinoma cells are sensitive to lysis by IL-2 stimulated decidual NK cells. Cell. Immunol. 1990.129: 435-448.
35. Tomasec, P., Braisa, V. M., Rickards, C., Powell, M. B., McSharry, B. P., Gadola, S., Cerundolo, V., Borysiewicz, L. K., McMichael, A. J. and Wilkinson, G. W. G., Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 2000. 287:1031-1033.
36. Avril, T., Jarousseau, A. C., Watier, H., Boucrat, J., Le Bouteiller, P., Bardos, P. and Thibault, G., Trophoblast cell line resistance to NK lysis mainly involves an HLA class l-independent mechanism. J. Immunol. 1999.162: 5902-5909.
37. Vitale, M., Bottino, C., Sivori, S., Sanserverino, L., Castriconi, R., Marcenaro, E., Augugliaro, R., Moretta, L. and Moretta, A., NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 1998. 187: 2065-2072.
38. Jokhi, P. P., King, A., Sharkey, A. M., Smith, S. K. and Loke, Y. W., Screening for cytokine mRNAs in purified human decidual lymphocyte populations by the reverse-transcriptase polymerase chain rection (RT-PCR). J. Immunol. 1994.153: 4427-4435.
39. Loke, Y. W. and King, A., Immunological aspects of human implantation. J. Reprod. Fertil. 55: 83-90.
40. Aguila, H. L. and Weissman, I. L., Hematopoietic stem cells are not direct cytotoxic targets of natural killer cells. Blood 1996.87: 1225-1231.
41. + T lymphocytes. J. Immunol. 1990. 147: 714-721.
42. Pérez-Villar, J. J., Melero, I., Rodriguez, A., Carretero, M., Arumburu, J., Sivori, S., Orengo, A. M., Moretta, A. and Lopez-Botet, M., Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. J. Immunol. 1997. 154: 5779-5788.
43. Phillips, J. H., Chang, C., Mattson, J., Gumperz, J. E., Parham, P. and Lanier, L. L., CD94 and a novel associated protein (94AP) from a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. Immunity 1996. 5: 163-172.
44. Carretero, M., Cantoni, C., Bellön, T., Bottino, C., Biassoni, R., Rodriguez, A., Perez-Villar, J. J., Moretta, L., Moretta, A. and Lôpez-Botet, M., The CD94 and NKG2A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur. J. Immunol. 1997. 27: 563-567.
45. + natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J. Exp. Med. 1990.172:1589-1598.
46. Moretta, A., Vitale, M., Bottino, C., Orengo, A. M., Morelli, L., Augugliaro, R., Barbares!, M., Ciccone, E. and Moretta, L., P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class l-protected cells in NK clones displaying different specificities. J. Exp. Med. 1993. 178: 597-604.